Drug
Lutropin alfa clinical trials
Also written Luveris.
Keep track of what changes. Save the lutropin alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
18 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 2 |
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 9
Merck KGaA, Darmstadt, Germany (4) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (3) · EMD Serono (2) · Peter y. Liu (1) · D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology (1) · Sisli Hamidiye Etfal Training and Research Hospital (1) · University of Saskatchewan (1) · Ellen Greenblatt (1)
Often tested with
Tested in the same studies.
Follitropin alfa (8) · Ketoconazole (1) · Ganirelix (1) · Dexamethasone (1) · Cosyntropin (1) · Hydrocortisone (1) · Corifollitropin alfa (1) · Menotropins (1)
Studies
Open first, then newest update. How each study uses lutropin alfa is read from its arms, and is right about nine times in ten.
Testing it · 18
- A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)RecruitingPhase 3Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT07340827Written as Follitropin alfa/lutropin alfa (MBJ-0011)
- FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility PatientsNot yet recruitingPhase 3Ellen GreenblattNCT06227949Written as Luveris
- Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism MenRecruitingPhase 2Azienda Ospedaliero-Universitaria di ModenaNCT04189133Written as Lutropin alfa
- An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian OriginCompletedPhase 1Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT07269327Written as Follitropin alfa/lutropin alfa
- Hormonal Mechanisms of Sleep Restriction - Axis StudyActive, not recruitingPhase 1Peter y. LiuNCT03142893Written as Recombinant Human Luteinizing Hormone
- Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian RespondersWithdrawnPhase 4CRG UZ BrusselNCT05405686Written as Lutropin alfa
- Pergoveris FD and Liquid China BE StudyCompletedPhase 1Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT04899193Written as Luveris
- Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal RespondersCompletedPhase 4D.O. Ott Research Institute of Obstetrics, Gynecology, and ReproductologyNCT03177538Written as Follitropin alfa and lutropin alfa
- A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive TechniqueTerminatedPhase 3Merck KGaA, Darmstadt, GermanyNCT01497197Written as Luveris®
- Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic HypogonadismStatus unknownPhase 4Royan InstituteNCT02140515Written as Lutropin alfa
- The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSICompletedPhase 4Sisli Hamidiye Etfal Training and Research HospitalNCT02108223Written as r-LH supplementation
- A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive AgeTerminatedPhase 2Merck KGaA, Darmstadt, GermanyNCT01079949Written as r-hLH + r-hFSH
- A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive AgeTerminatedPhase 2Merck KGaA, Darmstadt, GermanyNCT01075815Written as Recombinant human luteinizing hormone (rhLH)
- A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic HypogonadismCompletedPhase 3Merck KGaA, Darmstadt, GermanyNCT01084265Written as Recombinant human luteinizing hormone (r-hLH)
- A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive TechnologiesCompletedPhase 3EMD SeronoNCT01121991Written as Recombinant Human-Luteinizing Hormone (Luveris)
- Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])TerminatedPhase 4EMD SeronoNCT00328926Written as Luveris® 75 IU
- Synchronization of Follicle Wave Emergence and Ovarian StimulationCompletedPhase 4University of SaskatchewanNCT00439829Written as Luveris
- To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary DownregulationStatus unknownPhase 2Peking University Third HospitalNCT01029470Written as Luveris
Given in every arm · 1 — lutropin alfa is usual care beside what is tested
Codes
What other systems call lutropin alfa · ClinicalTrials.gg INT014681
- UNII (FDA) 3JGY52XJNALUTROPIN ALFAConfirmed FDA, Wikidata
- RxNorm 388084Confirmed FDA, Wikidata
- Wikidata Q208360lutropin alfaConfirmed FDA, Wikidata
- NCI Thesaurus C61818Lutropin AlfaOne source FDA
- DrugBank DB00044One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3JGY52XJNA | LUTROPIN ALFA | Confirmed FDA, Wikidata |
| RxNorm | 388084 | — | Confirmed FDA, Wikidata |
| Wikidata | Q208360 | lutropin alfa | Confirmed FDA, Wikidata |
| NCI Thesaurus | C61818 | Lutropin Alfa | One source FDA |
| DrugBank | DB00044 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.